NTBL (Notable Labs, Ltd.) Kacepetan wutah bathi saben saham ing taun lumaku
Notable Labs, Ltd. (NTBL) is scaling its IT system for predicting drug efficacy to capture a share of the oncology market. The relative annual growth in net income per share illustrates the dynamics of this expansion, where 28.50 serves as the final level marker. Stable management is successfully implementing live-cell screening, strengthening confidence through biotech partnerships. Leadership is focusing on clinical validation of precision therapy selection for treating complex forms of cancer.
Rincian metrik keuangan lan pasar notablelabs.com (NTBL)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Utang Agregat marang Modal Notable Labs, Ltd.|NTBL - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Notable Labs|NTBL - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Notable Labs, Ltd.|NTBL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Notable Labs|Likuiditas darurat notablelabs.com
- statistik bathi lan rasio pasar:
NTBL - Penghasilan resik|Penghasilan resik sing dikarepake Notable Labs, Ltd.|NTBL - Rasio rega marang bathi|Rega marang bathi mangsa ngarep Notable Labs, Ltd.|NTBL - Pangali PEG|Pangali EV/EBITDA Notable Labs|NTBL - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Notable Labs|NTBL - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan notablelabs.com|NTBL - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Notable Labs, Ltd.
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental:Notable Labs Corp, NTBL
This indicator measures the year-over-year dynamics of net income per share, determining the efficiency of business monetization and the growth rate of real income. The localization of R&D in the US and the absence of trade barriers for Notable Labs, Ltd. (NTBL) make the YoY net income per share change ratio a transparent tool for assessing operational stability. The positive trend confirms the capitalization of the technological advantage in personalized oncology therapy.
Pesaing utama
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Y-mAbs Therapeutics, Inc. (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki AURA|Kacepetan wutah bathi saben saham ing taun lumaku candeltx.com CADL|Wutah bathi ing taun lumaku ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics Inc)|Tambahing bathi saben saham ing taun lumaku CTOR|tuhurabio.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Wutah bathi saben saham ing taun lumaku|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku tscan.com|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku XBiotech USA (XBIT)|CVM: Dinamika bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku ostherapies.com OSTX|Wutah bathi resik saben siji saham kanggo taun lumaku RADX (Radiopharm Theranostics Limited)|Artiva - Wutah bathi ing taun lumaku|ANL: Wutah bathi saben saham ing taun lumaku|VERU: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku renovarobio.com RENB|Wutah bathi saben saham ing taun lumaku muraloncology.com (MURA)|Wutah bathi resik saben siji saham kanggo taun lumaku KAPA|Wutah bathi ing taun lumaku OKUR (onkuretherapeutics.com)|Wutah bathi resik saben siji saham kanggo taun lumaku GDTC (CytoMed)|Curis - Wutah bathi ing taun lumaku|APLM: Wutah bathi saben saham ing taun lumaku|Tharimmune (THAR) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki Advanced Biomed Inc.|GNPX (Genprex Inc) - Wutah bathi ing taun lumaku|Calidi Biotherapeutics (CLDI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku SBFM|Wutah bathi saben saham ing taun lumaku XBIO (Xenetic Biosciences, Inc.)|Wutah bathi ing taun lumaku SLRX (salariuspharma.com)|PPBT - Wutah bathi resik saben saham ing taun iki|AONC - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku BGNE (BeOne Medicines)|CKPT: Wutah bathi ing taun lumaku|Elevation Oncology Inc. (ELEV) - Wutah bathi ing taun lumaku|ICAD (iCAD) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku ikenaoncology.com|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Corporation MOR|NAYA Biosciences - Wutah bathi resik saben saham ing taun iki|Owah-owahan bathi resik saben saham ing taun lumaku Ascentage Pharma
